BCRX
BioCryst Pharmaceuticals, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website biocryst.com
- Employees(FY) 531
- ISIN US09058V1035
Performance
+23.19%
1W
+14.35%
1M
-4.54%
3M
-11.3%
6M
-12.19%
YTD
-38.04%
1Y
Profile
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor for complement-mediated diseases; and Galidesivir, to treat various RNA viruses, including Marburg, Yellow Fever, Ebola, and Zika. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.
Investment Analysis Report: BCRX
Overview
BCRX is a biotechnology company operating in the Health Technology sector with a market capitalization of $1.21 billion. The company's financial data provides insights into its valuation, financial health, earnings and revenue growth, profitability, operating margin, operating cash flow, and capital expe...
Technical Analysis of BCRX 2024-05-03
Overview:
In analyzing the technical indicators for BCRX over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions to guide your invest...
Recent News & Updates
- 2024-05-07 07:00
BioCryst to Present at Upcoming Investor Conferences(GlobeNewswire)
- 2024-05-07 06:23
- 2024-05-07 03:01
- 2024-05-07 01:13
Q1 2024 BioCryst Pharmaceuticals Inc Earnings Call(Thomson Reuters StreetEvents)
- 2024-05-06 19:00
BioCryst to Present at Upcoming Investor Conferences(Globenewswire)
- 2024-05-06 18:47
- 2024-05-06 16:59
- 2024-05-06 13:00
- 2024-05-06 12:35
- 2024-05-06 12:35
BioCryst Pharmaceuticals, Freshpet rise; Luminar, Integra fall, Tuesday, 5/6/2024(Associated Press Finance)
- 2024-05-06 08:32
- 2024-05-06 07:10
BioCryst: Q1 Earnings Snapshot(Associated Press Finance)
- 2024-05-06 07:00
- 2024-05-05 23:53
- 2024-05-05 23:45
BioCryst Pharmaceuticals Shares Jump After Q1 Beat(Yahoo Finance)
- 2024-05-05 20:10
- 2024-05-05 20:10
- 2024-05-05 19:00
- 2024-05-03 07:00
- 2024-05-02 19:00
- 2024-04-30 10:01
- 2024-04-29 10:00
- 2024-04-28 22:00
- 2024-04-22 08:04
- 2024-04-22 07:00
- 2024-04-21 19:00
- 2024-04-17 04:30
- 2024-04-16 17:14
Orladeyo gains approval in Brazil for HAE prevention(Pharmaceutical-business-review)
- 2024-04-16 16:30
- 2024-04-10 18:09
12 Best Depressed Stocks To Buy in 2024(Insider Monkey)
Page 1 of 6
previousnext